Startup's AI agent injects gene therapy into live mouse brain
A biotech firm allowed an AI agent to pick a gene therapy and deliver it into a mouse's brain.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
A biotech firm allowed an AI agent to pick a gene therapy and deliver it into a mouse's brain. The agent controlled a motorized surgery rig, and it was given free rein to treat epilepsy after another AI model declined to carry out the experiment.
Why it matters
They also present it as a glimpse of how research labs may work in the future.
Coverage
- Startup uses AI agent to perform controversial brain surgery on a mouse, Anthropic Sonnet controlled motorized surgery rig — AI given free rein to treat epilepsy with a range of gene therapy vectors after Opus 5.5 refused to conduct biological experiment (tomshardware.com)
- An AI Agent Injected Drugs Into a Live Mouse’s Brain (wired.com)
- A Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making (the-decoder.com)
- An AI Agent Just Performed A Brain Operation (NDTV)
More from Technology & AI
- China puts humanoid robots to work serving food and sorting parcels
- Newsom proposes sweeping AI safety rules for Washington
- Google releases Gemini 4 Neon AI model with million-token context
- Microsoft and Intel widen their cloud chip partnership
- Google DeepMind rolls out Genie 4 to select subscribers
- AI helped AMD shorten chip design work, OpenAI says